DENVER — Treatment with cannabidiol led to significant seizure reduction in those with focal-onset epilepsy and demonstrated a favorable safety profile, according to research presented at the American Academy of Neurology annual meeting.
“Four-year [Expanded Access Program] results demonstrated that [cannabidiol] was associated with sustained seizure improvement in

Related Keywords

United States , Denver , Colorado , American , Shenaz Bagha , Karthik Rajasekaran , Byrobert Herpen , Jazz Pharmaceuticals , Access Program , American Academy Of Neurology , Robert Herpen , American Academy , Expanded Access Program ,